Ovid Therapeutics Inc. (OVID) Earnings
|
Expand Research on OVID
| Next EPS Date | 11/11/26 | EPS Growth Rate | +47.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +12.3% | Revenue Growth Rate | -81.8% |
| Average % Move 1-Wk after EPS | -4.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.09 | N/A | N/A | $23.67K | N/A | N/A | N/A | ||
| 8/18/26 |
Q226 | N/A | -$0.12 | N/A | N/A | $56.25K | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$0.12 | -$0.12 | $0.00 | N/A | $56.67K | N/A |  | | Details | |
| 3/16/26 |
Q425 | N/A | -$0.11 | N/A | N/A | $80.67K | N/A | N/A | N/A | ||
| 11/12/25 | Q325 | -$0.17 | -$0.15 | -$0.02 | $130K | $227.17K | N/A | | | Details | |
| 8/13/25 |
Q225 | -$0.06 | -$0.16 | +$0.10 | $6.3M | $67.8K | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.14 | -$0.14 | $0.00 | $130K | $79.6K | N/A | | | Details | |
| 5/12/25 |
Q125 | N/A | -$0.14 | N/A | N/A | $79.6K | N/A | N/A | N/A |
